Jazz Pharmaceuticals (NasdaqGS:JAZZ) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsJohn Bluth - Head of Investor RelationsMichael Riad - VPMohit Bansal - Managing DirectorPhil Johnson - EVP and CFORenee Gala - President and CEORob Iannone - EVP of Research and DevelopmentSam Pearce - Chief Commercial OfficerNone - ShareholderConference Call ParticipantsAmi Fadia - Senior AnalystBrian Skorney - Senior Research AnalystDavid Amsellem - Managing Director and Senior Research AnalystDavi ...

Jazz Pharmaceuticals (NasdaqGS:JAZZ) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsJohn Bluth - Head of Investor RelationsMichael Riad - VPMohit Bansal - Managing DirectorPhil Johnson - EVP and CFORenee Gala - President and CEORob Iannone - EVP of Research and DevelopmentSam Pearce - Chief Commercial OfficerNone - ShareholderConference Call ParticipantsAmi Fadia - Senior AnalystBrian Skorney - Senior Research AnalystDavid Amsellem - Managing Director and Senior Research AnalystDavi ...

Jazz Pharmaceuticals (NasdaqGS:JAZZ) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Speaker12Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star one one on your telephone. You will then hear an automated message advising your hand is ...